Bedaquiline Adherence Measured by Electronic Dose Monitoring Predicts Clinical Outcomes in the Treatment of Patients with Multidrug-Resistant Tuberculosis and HIV/AIDS

O’Donnell, M. R., Padayatchi, N., Wolf, A., Zelnick, J., Daftary, A., Orrell, C., Nimmo, C., Baldwin, M., Boodhram, R., Maharaj, B., Amico, K. R., Naidoo, K., & Friedland, G. (2022). Bedaquiline Adherence Measured by Electronic Dose Monitoring Predicts Clinical Outcomes in the Treatment of Patients With Multidrug-Resistant Tuberculosis and HIV/AIDS. JAIDS Journal of Acquired Immune Deficiency Syndromes, 90(3), 325–332. https://doi.org/10.1097/qai.0000000000002940

Authors:

Max R. O'Donnell

Nesri Padayatchi

Allison Wolf

Jennifer Zelnick

Amrita Daftary

Catherine Orrell

Camus Nimmo

Matthew Baldwin

Resha Boodhram

Bhavna Maharaj

K. Rivet Amico